2024 Rising Star Investor Dinner

Description

Join BioNTX for an evening where you will meet our Rising Stars who are emerging startups in life sciences and healthcare innovation. Discover the groundbreaking work they are doing and take the opportunity to connect with future leaders shaping the industry. Don’t miss out on being part of their remarkable journeys!

2024 Rising Stars

Almaden Genomics accelerates scientific discovery for bioinformaticians and their teams through its intuitive and user-friendly g.nome platform. This visual workspace allows anyone from the team to drag and drop toolkits from a curated library, speeding pipeline development from months to minutes.

CorInnova is developing a minimally invasive, non-blood contacting cardiac assist device for acute heart failure treatment. The device is intended to initially treat the large and fast-growing short-term cardiac assist market. The device prototypes are being manufactured within FDA and CE mandated medical design control systems.

GenrAb is a preclinical stage company harnessing the power of the human immune system to develop therapies that can protect and treat patients with neurological disease. GenrAb has identified a target for its lead neuroprotective antibody therapy, TGM-010, which plays an important role in managing neuronal survival.

Island Pharmaceuticals is a drug research and repurposing company, focused on developing preventative or therapeutic drugs for viral infections. Island has repurposed ISLA-101, an antiviral oral drug to treat mosquito-borne viruses (eg dengue fever / Zika) and is planning to move forward with Phase II studies with a significantly de-risked clinical program.

Opsin Biotherapeutics is a joint venture that combines the expertise in multi-characteristic opsins from Nanoscope Technologies LLC, with the medical device expertise of DesignPlex Biomedical LLC to create unique products and opioid alternatives for chronic pain management.

Panthera BioSolutions (PBS), a specialty biotechnology and pharmaceutical organization offering bespoke manufacturing solutions for life sciences research and innovation through their pilot GMP facility in Fort Worth, Texas. PBS is spearheading the introduction of ready-to-use, leasable cleanrooms in North Texas as well as offering 3rd party contract manufacturing.

SingleCell Biotechnology's platform targets aggressive cancers with assays replicating dormancy, migration, and clonogenicity of tumor stem cells—key drivers of recurrence. It enables high-throughput data for drug discovery, screening, and identifying targets to disrupt dormant and migrating cells, speeding development.

Solenic Medical, Inc. is a medical device company developing an innovative non-invasive treatment for infected metallic implants in the body. Solenic uses alternating magnetic fields (AMF) to eradicate biofilm on medical implants. This non-invasive treatment addresses complications from surgeries like knee, hip, and trauma implants, including plates and rods.

Thank you for your support!